The financing includes $30 million in Series B equity and a $10 million venture debt term sheet, according to a news relese.
The BEAR implant was launched in 2021 and have been used with more than 500 patients, Patrick McBrayer, president and CEO of Miach Orthopaedics, said in the release. The most recent city to add the implant is Buffalo, N.Y. where Peter Gambacorta, DO, completed the debut case.
The BEAR implant uses a patient’s own blood to bridge and repair their ACL.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
